Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mouse embryos cloned from brain tumors.

Leyi Li1, Michele C Connelly, Cynthia Wetmore

  • 1Department of Developmental Neurobiology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Cancer Research
|June 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mechanistic Insights into Starch-Polyphenol Complexation: Role of Structural Differences in Galloyl-Based Polyphenols.

Antioxidants (Basel, Switzerland)·2026
Same author

Complete Mitochondrial Genome of <i>Melophagus ovinus</i> from Qinghai-Tibet Plateau Provides Evidence for D-Loop Length Polymorphism.

Genes·2026
Same author

Inflammation-driven mitochondrial dysfunction and ROS accumulation orchestrate pulmonary fibrotic remodeling in sepsis.

Redox biology·2026
Same author

Stress Sensing Based on Upconversion Piezo-Luminescence Effect.

Inorganic chemistry·2026
Same author

Pathogenesis of Chronic Arthritis Due to Chikungunya Virus and Advances in Vaccine Development.

Viruses·2026
Same author

Differential emotional responses and relief mechanisms across social exclusion roles.

Cognitive, affective & behavioral neuroscience·2026
Same journal

SEPTIN7 Enhances Tumorgenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling.

Cancer research·2026
Same journal

TLR9 Agonists Potentiate Adoptive T Cell Therapy in Cancer through a B Cell-CD2 Costimulatory Axis.

Cancer research·2026
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
See all related articles

Cancer cells can be reprogrammed into normal cell types through epigenetic reprogramming. This study demonstrates that tumor cells can reverse oncogenesis, offering a new strategy for cancer research.

Area of Science:

  • Oncology
  • Developmental Biology
  • Epigenetics

Background:

  • Cancer cells evade growth control via genetic and epigenetic changes.
  • Epigenetic alterations alone can drive oncogenesis.
  • Epigenetic modification agents can revert malignant phenotypes.

Purpose of the Study:

  • To investigate the extent to which epigenetic reprogramming can reverse oncogenesis.
  • To determine if tumor cells can be reprogrammed into normal cell types.

Main Methods:

  • Somatic nuclear transfer technique was employed.
  • Medulloblastomas from Ptc1+/- mice were used.
  • Nuclear transfer into oocytes for preimplantation development.

Main Results:

Related Experiment Videos

  • Medulloblastomas could direct preimplantation development after nuclear transfer.
  • Blastocysts derived from medulloblastoma nuclei formed viable postimplantation embryos.
  • Tumor cell nuclei were reprogrammed into normal embryonic tissues.

Conclusions:

  • Epigenetic reprogramming can reverse oncogenesis in medulloblastoma cells.
  • Somatic nuclear transfer offers a method to assess epigenetic contributions to cancer.
  • This approach may lead to novel cancer treatment strategies.